D430-2029 Screening compound: N-(3-chlorophenyl)-4-[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperazine-1-carboxamide

D430-2029 Screening compound: N-(3-chlorophenyl)-4-[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperazine-1-carboxamide
D430-2029 Screening compound: N-(3-chlorophenyl)-4-[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D430-2029
N-(3-chlorophenyl)-4-[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D430-2029

Molecular Formula

C20H25ClN6O (C20 H25 ClN6 O)

Compound Name

N-(3-chlorophenyl)-4-[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperazine-1-carboxamide

IUPAC name

N-(3-chlorophenyl)-4-[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperazine-1-carboxamide

SMILES

Cc1nc(N2CCCC2)cc(N(CC2)CCN2C(Nc2cccc(Cl)c2)=O)n1

InChI

InChI=1S/C20H25ClN6O/c1-15-22-18(25-7-2-3-8-25)14-19(23-15)26-9-11-27(12-10-26)20(28)24-17-6-4-5-16(21)13-17/h4-6,13-14H,2-3,7-12H2,1H3,(H,24,28)

InChI Key

LPCKSMNBZXGKAR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD21609818

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

400.91

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.485

Distribution Coefficient, logD

4.461

Water Solubility, LogSw

-4.48

Polar Surface Area

49.897

Acid Dissociation Constant (pKa)

12.15

Base Dissociation Constant (pKb)

6.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.00

D430-2029 in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D430-2029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D430-2029?
Check Price and Availability of D430-2029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D430-2029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D430-2029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D430-2029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D430-2029 available by request